Operating
Accrued compensation and employee benefits
Year-over-year, this metric declined by 7750.0%, from -$600K to -$47.1M. Over 2 years (FY 2021 to FY 2025), Accrued compensation and employee benefits shows an upward trend with a 133.3% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
First reportedQ1 2013
Last reportedQ1 2026Apr 30, 2026
Metric ID:
operating_increase_decrease_in_employee_related_liabilitiesHistorical Data
16 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $16.8M | $16.7M | $9.9M | -$40.5M | $22.5M | -$39.3M | $13.8M | $42.1M | $20.6M | -$60.7M | -$9.1M | -$600K | $15.9M | $41.3M | $0 | -$47.1M |
| QoQ Change | — | -0.6% | -40.7% | -509.1% | +155.6% | -274.7% | +135.1% | +205.1% | -51.1% | -394.7% | +85.0% | +93.4% | >999% | +159.7% | -100.0% | — |
| YoY Change | — | — | — | — | +127.3% | +3.0% | — | — | -8.4% | -54.5% | -121.6% | +99.0% | — | +553.8% | — | <-999% |
Range-$60.7M – $42.1M
CAGR+31.6%
Avg YoY Growth-893.9%
Median YoY Growth-2.7%
Current Streak2 quarters decline
Accrued compensation and employee benefits at Other Companies
Frequently Asked Questions
- What is DexCom's accrued compensation and employee benefits?
- DexCom (DXCM) reported accrued compensation and employee benefits of -$47.1M in Q1 2026.
- How has DexCom's accrued compensation and employee benefits changed year-over-year?
- DexCom's accrued compensation and employee benefits decreased by 7750.0% year-over-year, from -$600K to -$47.1M.
- What is the long-term trend for DexCom's accrued compensation and employee benefits?
- Over 2 years (2021 to 2025), DexCom's accrued compensation and employee benefits has grown at a 133.3% compound annual growth rate (CAGR), from $10.4M to $56.6M.